Press Releases from Merlin Biotechnologies (2 total)
Hedge fund takeover of Merlin Biotechnologies stock
Canadian based medical marijuana genius in final discussions with global Hedge Fund for monumental take over. "ABC" Hedge Fund ( name protected by NDA ) have seen the obvious growth potential in Merlin Biotechnologies and been creeping on the side lines waiting to pounce. Now Merlin are set to list on the NYSE in May 2020, a prestigious hedge fund have made an impressive offer to purchase a controlling stake.
TFR Global Appointed As Approved Brokerage For Merlin Biotech
Merlin Biotechnologies are pleased to confirm that TFR Global are now appointment as the company's approved brokerage to over-see their 3 rounds of private placement financing which will start early next year. Merlin Biotechnologies, a Canadian based bio-tech company whose focus is primarily on researching and developing clinically approved medicines, using various strains of marijuana, intend to float on the NYSE in the 3rd quarter of 2020. Their stage 1 round